Press Releases on August 1, 2024 - EIN Presswire - Press Release Distribution Service

Published on August 1, 2024 - 20:05 GMT

CNB Financial Corporation Announces Quarterly Dividend for Series A Preferred Stock and Related Depositary Shares Distribution

CLEARFIELD, Pa., Aug. 01, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of CNB Financial Corporation (Nasdaq: CCNE) (the "Corporation") has announced the declaration of a quarterly cash dividend of $0.4453125 per depositary share (Nasdaq: CCNEP …

Distribution channels: Banking, Finance & Investment Industry ...

Published on August 1, 2024 - 20:05 GMT

Professor and Mother of Three Wants to Empower Local Youth in No. Carolina Through STEAM Education with IDEA Lab® Kids

Mag Atem found the STEAM education franchise when she was searching for a program where her own children could learn. LAGUNA NIGUEL, CA, UNITED STATES, August 1, 2024 /⁨EINPresswire.com⁩/ -- As a mother of three young girls, Mag Atem’s franchising …

Distribution channels: Education, Science ...

Published on August 1, 2024 - 20:05 GMT

Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update

Second quarter total revenue of $147 million, Crysvita® revenue of $114 million and Dojolvi® revenue of $19 million Increased 2024 expected total revenue guidance to $530 million to $550 million NOVATO, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Ultragenyx …

Distribution channels:

Published on August 1, 2024 - 20:05 GMT

INmune Bio Inc. Announces Second Quarter 2024 Results and Provides Business Update

Company to Host Conference Call Today, August 1, at 4:30pm ET BOCA RATON, Fla., Aug. 01, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company developing treatments that harness the …

Distribution channels:

Published on August 1, 2024 - 20:05 GMT

Brisbane Anxiety Treatment Centre Launch by Avive Health Best Private Mental Health Hospital At 16 Bryden Street, Windsor QLD 4030

Brisbane City, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Brisbane City, Queensland - Avive Clinic Brisbane, a leading private mental health hospital,, has today revealed more about its unique and progressive treatment approach to address mental health issues, …

Distribution channels: Media, Advertising & PR ...

Published on August 1, 2024 - 20:05 GMT

Arteris Announces Financial Results for the Second Quarter 2024 and Third Quarter and Full Year 2024 Guidance

CAMPBELL, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced financial results for the second quarter ended June 30, 2024 and provided …

Distribution channels:

Published on August 1, 2024 - 20:05 GMT

Opendoor Announces Second Quarter of 2024 Financial Results

SAN FRANCISCO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. (Nasdaq: OPEN), a leading e-commerce platform for residential real estate transactions, today reported financial results for its second quarter ended June 30, 2024. Opendoor’s …

Distribution channels:

Published on August 1, 2024 - 20:05 GMT

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the “Company”), a clinical stage biopharmaceutical company focused on the discovery and development of covalent small molecules to treat patients with …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on August 1, 2024 - 20:05 GMT

LeMaitre Q2 2024 Financial Results

BURLINGTON, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2024 results, announced a $0.16/share quarterly dividend and provided guidance. Q2 2024 Financial Results …

Distribution channels:

Published on August 1, 2024 - 20:05 GMT

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

LAUSANNE, Switzerland, Aug. 01, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made grants of options to purchase …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on August 1, 2024 - 20:05 GMT

ADC Therapeutics gewährt neuen Mitarbeitern Zuteilungen im Rahmen des Anreizplans

LAUSANNE, Schweiz, Aug. 01, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT), ein weltweit führendes Unternehmen im kommerziellen Stadium und Pionier auf dem Gebiet der Antikörper-Wirkstoff-Konjugate (ADCs), hat heute bekanntgegeben, dass das …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on August 1, 2024 - 20:05 GMT

Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2024 Financial Results

SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report second quarter 2024 financial …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on August 1, 2024 - 20:05 GMT

Sprout Social Announces Second Quarter 2024 Financial Results Ahead of Guidance Range

CHICAGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today announced financial results for its second quarter ended June …

Distribution channels:

Published on August 1, 2024 - 20:05 GMT

Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update

Following Positive End of Phase 2 Meeting with FDA, Company Continues to Advance Plans for Phase 3 Placebo-Controlled Trial of LUM-201 in Moderate Pediatric Growth Hormone Deficiency Expects to Initiate Phase 3 Trial in Q2 2025 Company to Host Conference …

Distribution channels:

Published on August 1, 2024 - 20:05 GMT

Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results

SEATTLE, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products …

Distribution channels:

Published on August 1, 2024 - 20:05 GMT

Oncocyte to Announce Second Quarter 2024 Financial Results on August 8

IRVINE, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, announced today that the company will release its second quarter 2024 financial results on Thursday, August 8, 2024, after U.S. market close. …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on August 1, 2024 - 20:05 GMT

ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024

Year-over-year revenue grows 9%, operating profit up 38%, non-GAAP operating profit up 30% Operating cash flow of $440 million Quarterly dividend increases 10% to $0.53 per share Company to host an Investor Day on September 30, 2024 Note: A webcast of …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on August 1, 2024 - 20:05 GMT

Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates

Topline data from completed Phase 2/3 LIFT-AD clinical trial of fosgonimeton as a potential treatment for mild-to-moderate Alzheimer’s disease targeted for September 2024 Phase 2/3 LIFT-AD data to be presented in an oral presentation at CTAD in October …

Distribution channels:

Published on August 1, 2024 - 20:05 GMT

Myriad Genetics Advances International Reorganization and Completes Sale of EndoPredict Business to Eurobio Scientific

SALT LAKE CITY, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it completed the sale of its EndoPredict® business to Eurobio Scientific, a leading French group in …

Distribution channels: Companies, Technology ...

Published on August 1, 2024 - 20:05 GMT

DMC Global Reports Second Quarter Financial Results

Second quarter sales were $171.2 million, up 3% sequentially and down 9% vs. Q2 2023 Net income was $6.3 million, while net income attributable to DMC was $4.0 million Adjusted net income attributable to DMC* was $5.7 million, or $0.29 per diluted share …

Distribution channels: